Breast Neoplasms: all 12,828 studies
Page 65 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of ChemotherapyStatus unknownNCT05097248Phase 2
- Genetic Predictors of Response to Acupuncture for Cancer-related Fatigue Among Breast Cancer Patients After ChemotherapyStatus unknownNCT05094310Not applicable
- SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast CancerWithdrawnNCT05093387Phase 1
- ABCB1 SNPs as Predictors of PIPNCompletedNCT05093023
- Integrated Intervention for Breast Cancer Survivors With DiabetesCompletedNCT05092477Not applicable
- The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh PopulationCompletedNCT05090605
- Preventing High Blood Sugar in People Being Treated for Metastatic Breast CancerActive, not recruitingNCT05090358Phase 2
- Breast Cancer and Kinesiophobia and Physical ActivityCompletedNCT05090098
- Breast Cancer Outreach Among Primary Care PatientsCompletedNCT05089903Not applicable
- Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast CancerStatus unknownNCT05089643Phase 2
- Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast CancerActive, not recruitingNCT05088785Not applicable
- Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast CancerStatus unknownNCT05088057Phase 2
- Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast CancerCompletedNCT05086731Not applicable
- Co'Moon for Supporting Breast Cancer Patients on Adjuvant Endocrine TherapyCompletedNCT05085678Not applicable
- Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast CancerStatus unknownNCT05085626Phase 2
- FH-Risk 2.0: Updating Breast Cancer Risk EstimatesCompletedNCT05082740
- Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web SyndromeCompletedNCT05082597Not applicable
- A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast CancerTerminatedNCT05080842Phase 1
- Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerWithdrawnNCT05079360Phase 2
- Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast CancerCompletedNCT05079074
- Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast CancerActive, not recruitingNCT05078190
- A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast CancerActive, not recruitingNCT05077449Phase 3
- Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast CancerStatus unknownNCT05076695Phase 2
- StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer PatientsWithdrawnNCT05073172Not applicable
- Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using AlpelisibCompletedNCT05073120
- Mobile Application Support for Women With Breast Cancer Undergoing ChemotherapyStatus unknownNCT05072197Not applicable
- Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast CancerCompletedNCT05071677
- Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-basedCompletedNCT05071560Not applicable
- Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine TherapyActive, not recruitingNCT05069038Phase 2
- Shear Wave Elastography Assessment of Neoadjuvant Chemotherapy Response in Patients With Invasive Breast CancerStatus unknownNCT05068999
- Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer PatientsTerminatedNCT05068726
- A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)Status unknownNCT05068141Phase 2
- Characteristics and Treatment Trends of Young Breast Cancer in ChinaStatus unknownNCT05068115
- Hepatitis C Screening Paired With MammographyCompletedNCT05067374
- Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast CancerTerminatedNCT05065411Phase 3
- Exercise as Medicine for People With Cancer SwedenCompletedNCT05064670Not applicable
- Correlation Between PET/CT Parameters and Tumor Markers in Recurrent Breast CancerStatus unknownNCT05064475
- Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer PatientsCompletedNCT05064098
- Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast CancerCompletedNCT05064085Phase 1
- Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in PIK3CA-mutated HER2+ Advanced BC (ALPHABET)TerminatedNCT05063786Phase 3
- Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High AltitudeStatus unknownNCT05063643
- Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major DepressionTerminatedNCT05063604Phase 2
- Cancer Patient Perspectives During COVID-19CompletedNCT05062538
- Breast Cancer BRCA1 Carriers: a Pilot StudyWithdrawnNCT05062174
- Effect of Intravenous S-ketamine on Opioid ConsumptionCompletedNCT05060068Not applicable
- The Effect of Mobile Lymphedema Self-Care Support Program on Self-Care in Women With Breast Cancer-related LymphedemaCompletedNCT05058495Not applicable
- Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast CancerCompletedNCT05058196Not applicable
- The Effect of Mindfulness Program on Spiritual Well-BeingBreast Cancer PatientsCompletedNCT05057078Not applicable
- Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple DischargeActive, not recruitingNCT05056844Not applicable
- Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)Active, not recruitingNCT05056077Not applicable
- The Psychology of Chinese Breast Cancer PatientsStatus unknownNCT05055375
- Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS CohortStatus unknownNCT05054777
- GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast CancerCompletedNCT05054751Phase 3
- Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations StudyCompletedNCT05054166
- Identification of Breast Cancer Specific Markers in Patients Compared to Healthy ParticipantsActive, not recruitingNCT05054010
- Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer WomenCompletedNCT05053841Phase 2
- PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast CancerCompletedNCT05052437Phase 1
- Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?Status unknownNCT05051956
- Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast NeoplasiaStatus unknownNCT05050890
- Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular RiskCompletedNCT05049031Not applicable
- Effectiveness of Mobile Messenger-initiated Reminder on Biannual Mammography Adherence in Breast Cancer ScreeningStatus unknownNCT05048641Not applicable
- Remote Assessment of Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers in Breast Cancer SurvivorsCompletedNCT05048108
- Artificial Intelligence in Breast Cancer Screening in Region Östergötland LinkopingCompletedNCT05048095
- Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast CancerStatus unknownNCT05047848Not applicable
- Remote Electronic Assessment of Survivors With Feedback Communication and Directed ReferralsCompletedNCT05047575Not applicable
- Contrast-Enhanced Mammography for the Evaluation of Mammographic MicrocalcificationsActive, not recruitingNCT05046301
- A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast CancerStatus unknownNCT05044988Phase 2
- European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal TherapiesCompletedNCT05043506
- The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy ProceduresCompletedNCT05042999Not applicable
- Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain SyndromeWithdrawnNCT05041751Not applicable
- Exercise Prescription Guided by Heart Rate Variability in Breast Cancer PatientsStatus unknownNCT05040867Not applicable
- A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid TumorsWithdrawnNCT05039931Phase 1
- Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.Active, not recruitingNCT05038735Phase 3
- SIGNAL During a COVID-19 PandemicWithdrawnNCT05037019Not applicable
- Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild CardiotoxicityActive, not recruitingNCT05036252
- Cone Beam Breast CT for Breast Cancer ScreeningActive, not recruitingNCT05036096Not applicable
- Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)Status unknownNCT05036005Phase 4
- The LYSA (Linking You to Support and Advice) TrialCompletedNCT05035173Not applicable
- Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in BrazilCompletedNCT05034393
- Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast CancerStatus unknownNCT05033769Phase 4
- Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDOActive, not recruitingNCT05033756Phase 2
- Prognostic Indicators for Radiation-induced Breast FibrosisTerminatedNCT05031065
- An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer SurvivorsCompletedNCT05030792Not applicable
- A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast CancerStatus unknownNCT05030519
- Oral Aromatase Inhibitors Modify the Gut MicrobiomeCompletedNCT05030038
- Ask Questions (ASQ):Implementation of a Communication InterventionCompletedNCT05025748Not applicable
- Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast CancerStatus unknownNCT05025735Phase 2
- Use of an Interactive 3D Tool During Consultation for Breast Reconstruction SurgeryActive, not recruitingNCT05025020Not applicable
- Artificial Intelligence for breaST canceR scrEening in mAMmography (AI-STREAM)Active, not recruitingNCT05024591
- Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-worldCompletedNCT05022342
- Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older AdultsCompletedNCT05021172Not applicable
- Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density CategorizationStatus unknownNCT05021055
- Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and PyrotinibStatus unknownNCT05020964Phase 2
- Life After Breast Cancer - Impact of a Life CoachStatus unknownNCT05020561Not applicable
- Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 StudyCompletedNCT05019989Not applicable
- Investigating the Long-term Cardiac Sequelae of Trastuzumab TherapyStatus unknownNCT05019365
- ARX788 in HER2-positive Breast Cancer Patients With Brain MetastasesStatus unknownNCT05018702Phase 2
- ARX788 in Breast Cancer With Low Expression of HER2Status unknownNCT05018676Phase 2
- Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.Status unknownNCT05016349Phase 3
- A Study of High-Dose Vit D Versus Standard of Care Vit D SupplementationCompletedNCT05016310Not applicable